TenderDekho Logo
GEM

Tender Notice for Bicalutamide Tablets (V2) in NORTH DELHI, DELHI

Bid Publish Date

02-Apr-2025, 2:05 pm

Bid End Date

12-Apr-2025, 3:00 pm

Progress

Issue02-Apr-2025, 2:05 pm
AwardPending
Explore all 5 tabs to view complete tender details

Quantity

3500

Bid Type

Two Packet Bid

Categories 4

Public procurement opportunity for Delhi State Cancer Institute (dsci) Bicalutamide Tablets (V2) (Q2) in NORTH DELHI, DELHI. Quantity: 3500 issued by. Submission Deadline: 12-04-2025 15: 00: 00. View full details and respond.

Documents 3

GeM-Bidding-7689964.pdf

Main Document

GeM Category Specification

GEM_CATEGORY_SPECIFICATION

GEM General Terms and Conditions Document

GEM_GENERAL_TERMS_AND_CONDITIONS

Past Similar Tenders (Historical Results)

5 found

Acetazolamide Tablets (V2),Acyclovir Tablets (V2),Amiodarone Tablets (V2),Bicalutamide Tablets (V2)

N/A

JALANDHAR, PUNJAB

Posted: 30 June 2025
Closed: 17 July 2025
GEM

Blood Glucose Test Strips (V2)

All India Institute Of Medical Sciences (aiims)

WEST DELHI, DELHI

Posted: 26 May 2025
Closed: 16 June 2025
GEM

Biliary Stents (V2)

N/a

BHOPAL, MADHYA PRADESH

Posted: 18 November 2025
Closed: 24 November 2025
GEM

Biliary Stents (V2)

N/a

BHOPAL, MADHYA PRADESH

Posted: 18 November 2025
Closed: 24 November 2025
GEM

Biliary Stents (V2)

N/a

BHOPAL, MADHYA PRADESH

Posted: 19 April 2025
Closed: 28 April 2025
GEM

🤖 AI-Powered Bidder Prediction

Discover companies most likely to bid on this tender

Live AI
Historical Data

Required Documents

1

Experience Criteria

2

Past Performance

3

Bidder Turnover

4

OEM Authorization Certificate

5

OEM Annual Turnover *In case any bidder is seeking exemption from Experience / Turnover Criteria

6

the supporting documents to prove his eligibility for exemption must be uploaded for evaluation by the buyer

Frequently Asked Questions

Key insights about DELHI tender market

What are the eligibility requirements for GEM/2025/B/6095430?

The eligibility requirements include being a registered entity with the necessary licenses to supply pharmaceutical products within India. Bidders must demonstrate a record of experience in the pharmaceutical sector, ensuring they meet quality and compliance standards set forth by authorities. Additionally, compliance with local regulations and presence in the market for a set duration enhances eligibility prospects.

What certifications are required for the Bicalutamide Tablets tender?

To participate in the tender, bidders must hold appropriate certifications such as Good Manufacturing Practice (GMP) certification alongside other mandatory quality certifications. These ensure that the supplied products adhere to established quality standards, thus safeguarding public health. Documentation showing compliance with pharmaceutical regulations and proof of manufacturing capability may also be required.

How should bidders register and submit documents for the tender?

Bidders must follow the prescribed registration process, which involves submitting a detailed bid proposal along with supporting documents. All documents should be submitted in accepted formats, ensuring clarity and compliance with the tender specifications. It's advisable to check any specific requirements stated in the tender for document submission protocols.

What payment terms are associated with the contract?

The payment terms for the tender will be disclosed to successful bidders upon contract finalization. Typically, payment may follow the completion of delivery or based on milestones agreed upon. Bidders should ensure they clarify payment expectations in their proposals.

Are there any benefits for MSEs participating in this tender?

Yes, Micro, Small, and Medium Enterprises (MSEs) can avail exemptions and benefits while participating in this tender. This includes preferential pricing considerations and potentially reduced documentation requirements. Bidders should highlight their MSE status in their submissions to gain favorable evaluation.